Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way

DOI Web Site 被引用文献4件
  • Ludovico Abenavoli
    Department of Health Sciences, University “Magna Graecia”, Viale Europa—Germaneto, 88110 Catanzaro, Italy
  • Luigi Boccuto
    Greenwood Genetic Center, 113 Gregor Mendel Circle, Greenwood, SC 29646, USA
  • Alessandro Federico
    Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, via Pansini 5, 80131 Naples, Italy
  • Marcello Dallio
    Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, via Pansini 5, 80131 Naples, Italy
  • Carmelina Loguercio
    Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, via Pansini 5, 80131 Naples, Italy
  • Laura Di Renzo
    Department of Biomedicine and Prevention, Section of Clinical Nutrition and Nutrigenomic, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy
  • Antonino De Lorenzo
    Department of Biomedicine and Prevention, Section of Clinical Nutrition and Nutrigenomic, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy

書誌事項

公開日
2019-08-21
権利情報
  • https://creativecommons.org/licenses/by/4.0/
DOI
  • 10.3390/ijerph16173011
公開者
MDPI AG

説明

<jats:p>Lifestyle interventions remain the first-line treatment for non-alcoholic fatty liver disease (NAFLD), even if the optimal alimentary regimen is still controversial. The interest in antioxidants has increased over time, and literature reports an inverse association between nutrients rich in antioxidants and the risk of mortality due to non-communicable diseases, including NAFLD. Mediterranean diet (MD) is a model characterized by main consumption of plant-based foods and fish and reduced consumption of meat and dairy products. MD represents the gold standard in preventive medicine, probably due to the harmonic combination of many foods with antioxidant and anti-inflammatory properties. This regimen contributes substantially to the reduction of the onset of many chronic diseases as cardiovascular diseases, hypertension, type 2 diabetes mellitus, obesity, cancer, and NAFLD. The present review aims to clarify the intake of antioxidants typical of the MD and evaluate their effect on NAFLD.</jats:p>

収録刊行物

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ